Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Investor Newsletters
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
18 Sep 2020
Change of Director's Interest Notice - Dr. Robert Peach
18 Sep 2020
Change of Director's Interest Notice - Dr. C. Burns
18 Sep 2020
Section 708A Cleansing Notice - Allotment of Shares
18 Sep 2020
Appendix 2A - Application for Quotation of Shares
18 Sep 2020
Results of Annual General Meeting
18 Sep 2020
CEO Presentation to AGM
08 Sep 2020
Amplia Receives Ethics Clearance to Conduct Phase 1 Trial
02 Sep 2020
Appendix 3G - Notification of Issue of Securities - Options
31 Aug 2020
Amplia Appoints Dr Mark Devlin as Chief Scientific Officer
17 Aug 2020
Notice of Annual General Meeting & Proxy - YE 31 March 2020
Previous
1
2
3
4
5
6
7
Next
